Sabina Heinz and Elizabeth Baynton look at how the continued absence of approved products affecting the management of NASH patients.
Sabina Heinz and Elizabeth Baynton
Advertisement
Dr. Sabina Heinz is Research Director at Ipsos Healthcare. Elizabeth Baynton is Associate Director at Ipsos Autoimmune Therapy Monitors.
Articles by Sabina Heinz and Elizabeth Baynton
Advertisement
Latest Updated Articles
NASH: Still WaitingPublished: June 3rd 2019 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Breyanzi for Adults with Relapsed or Refractory Marginal Zone Lymphoma
2
Mark Cuban Pushes for Generic Drug Fee Waivers, as Cost Plus Drugs Eyes US Manufacturing Expansion
3
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
4
Five Steps for Successful CGT Commercialization Through Health Systems Partnerships
5
